1 / 5

Global Clinical Laboratory Tests Market – Industry Trends and Forecast to 2029

Global Clinical Laboratory Tests Market, By Type of Test, Clinical (Complete Comprehensive Test or Complete Body Test), Complete Body Count, Basic Metabolic Panel (BMP), HGB/HCT), Tests, HbA1c Tests, BUN Creatinine Tests, Electrolytes Tests, Renal Panel Tests, Lipid Panel Tests, Routine, Speciality), Application (Parasitology, Haematology, Virology, Toxicology, Immunology/Serology, Histopathology and Urinalysis, End Users (Hospital Based Laboratories, Clinics Based Laboratories, Central/Independent Laboratories, Physician Office-Based Laboratories and Other - Retail Clinic) u2013 Industry Trends a

pawarmnk
Download Presentation

Global Clinical Laboratory Tests Market – Industry Trends and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Clinical Laboratory Tests Market – Industry Trends and Forecast to 2029  Clinical Laboratory Tests Market Analysis and Size According to World Health Organization data, more than 17 million people die each year from cardiovascular disorders caused by a variety of unhealthy behaviours, high blood pressure, and high cholesterol levels. Liver cirrhosis, hepatitis, liver cancer, bone disease, bile duct obstruction, and autoimmune disorders are all part of the liver panel segment. Hepatitis had the highest share in 2019, while liver cirrhosis was expected to be the fastest-growing segment over the forecast period due to rising lifestyle disorders and tobacco and alcohol consumption. https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-tests-market Data Bridge Market Research analyses that the clinical laboratory tests market which was USD 206,645.00 million in 2021, is expected to reach USD 399819.07 million by 2029, at a CAGR of 8.6% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

  2. Report Description https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-tests-market Market Definition Clinical laboratory test results are used in diagnostic decision making as part of clinical medicine. Clinical laboratory tests are classified into three types. The US Food and Drug Administration (FDA) determines the testing categories of tests that have been cleared for clinical use using a scoring system that considers the complexity of the testing, the stability of calibrators, controls, pre-analytical steps required, and the need for result interpretation. The test samples are analysed by a technician or your doctor to see if your results are within the normal range. Clinical laboratories are medical services that offer a wide range of research techniques to help doctors with diagnosis, therapeutic interventions, and patient supervision. Global Clinical Laboratory Tests Market Dynamics Drivers Growing geriatric population will bolster the growth rate The growing geriatric population is expected to drive the overall clinical laboratory test market. According to the World Population Prospects: the 2019 Revision data, approximately one in every eleven people in the world were over the age of 65 in 2019, and by 2050, it is estimated that approximately one in every six people will be over the age of 65. Clinical laboratory tests are being used more and more to diagnose age-related diseases. Furthermore, the rising rate of insufficient exercise, unhealthy food consumption, and the resulting rise in cases of obesity are expected to increase the prevalence of various chronic diseases. The growing awareness of the importance of regular body profiling among healthcare professionals and patients around the world is drive up demand for clinical laboratory tests.

  3. Market Overview • Opportunities • Innovative solutions in clinical laboratory tests • Innovative solutions for improving efficiency and eliminating errors are expected to be a major rendering driver in this industry. Integrated workflow management systems, database management tools, and patient test records are becoming increasingly important in the healthcare industry • Restraints/Challenges • Stringent governmental guidelines will restrict the growth rate • The stringent governmental guidelines and regulations on laboratory research are the main factors limiting the market growth. • Ambiguous regulatory framework • The healthcare industry relies heavily on regulatory frameworks established by organisations such as the FDA and EMA in the United States. • Recent developments • In April 2022, Quest Diagnostics, based in Secaucus, New Jersey, has announced a number of organisational changes and senior leadership appointments to better support the company's two-point business strategy of accelerating growth and driving operational excellence. • In April 2022, Abbott has updated its digital health app with its chronic pain neurostimulation devices, making it easier for clinicians to monitor how well patients respond to treatment. While using Abbott's Proclaim device range for spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy, the NeurospheremyPath app measures and reports patient-perceived pain relief and general well-being.

  4. Key Players • Some of the major players operating in the clinical laboratory tests market are: • Abbott (U.S.) • ARUP Laboratories (U.S.) • OPKO Health, Inc. (U.S.) • Bioscientia Healthcare GmbH (Germany) • Charles River Laboratories (U.S.) • NeoGenomics Laboratories (U.S.) • Genoptix, Inc. (U.S.) • Healthscope (Australia) • The Laboratory Glassware Co. (U.S.) • Laboratory Corporation of America® Holdings (U.S.) • Fresenius Medical Care AG & Co. KGaA (Germany) • QIAGEN (Germany) • Quest Diagnostics Incorporated (U.S.) • Siemens Healthcare Private Limited (Germany) • Tulip Diagnostics (P) Ltd. (India) • Sonic Healthcare Limited (Australia) • Merck KGaA (Germany) • https://www.databridgemarketresearch.com/reports/global-clinical-laboratory-tests-market

  5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com

More Related